CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 70 enrolled
Drug / intervention
sharing decision-making programbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03926039
NCT03926039N/ACompleted
CompareCT.gov

The Effectiveness of Sharing Decision-making Program Interventions in the Early Stage of HCC to Reduce Treatment Decisions Conflicts and Improving Decision-making Satisfaction

National Taipei University of Nursing and Health Sciences·interventional·Posted Apr 24, 2019·Updated Oct 29, 2021

In Brief

A clinical study evaluating sharing decision-making program for Hepatocellular Cancer. Completed, enrolled 70 participants across 1 site.

Detailed Summary

Aim: Explore the effectiveness of sharing decision-making program interventions in the early stage of HCC to reduce treatment decisions conflicts and improving decision-making satisfaction. Design: An experimental design will be used in the study. The 102 primary liver cancer patients, who were diagnosed with Barcelona stage(BCLC stage) 0-A, will be recruited and randomized to the control or intervention group. The intervention measures in this study "sharing decision-making plan" mainly includes sharing the decision-making talks and the decision-making assistance tools used in the process.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHepatocellular Cancer
CountriesTaiwan
CollaboratorsLotung Poh-Ai Hospital

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedApr 24, 2019
Enrollment StartMay 1, 2019
Primary CompletionMar 6, 2020
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 7.2 years ago

Interventions

sharing decision-making programbehavioral

Sharing decision-making talks and decision-making assistance tools used in the process